Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Come on everything is the same after years

<< Previous

Bullboard Posts

Next >>

Comment by malibukion Jun 13, 2022 12:21pm

140 Views

Post# 34752339

RE:RE:Come on everything is the same after years

I did not find anything. Is not it crystal clear? This supposed to be the deal of the company and price is barely green. They could even have paid Allergan to use their molecule. They are clowns. What is next another preclinal non sense which is the best of the best. Pet insulin blabla. Name a single achievement. Children born when 1067 was preclinical are now in the college. They did not show single head to head long term scientific study. Part er due diligence strategic hire. I am curious how long term holders can stand this non sense for years.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects